靶点针对疾病信息38(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
INDICATI
Approved Stomach cancer [ICD-11: 2B72]
INDICATI
Phase 3 Bladder cancer [ICD-11: 2C94]
INDICATI
Phase 3 Lymphoma [ICD-11: 2A80-2A86]
INDICATI
Phase 3 Neuroendocrine carcinoma [ICD-11: 2C34]
INDICATI
Phase 3 Oral cavity/oesophagus/stomach in situ carcinoma [ICD-11: 2E60]
INDICATI
Phase 3 Penile cancer [ICD-11: 2C81]
INDICATI
Phase 3 Squamous cell carcinoma [ICD-11: 2B60-2D01]
INDICATI
Phase 2 Cervical cancer [ICD-11: 2C77]
INDICATI
Phase 1 Metastatic tumour [ICD-11: 2D50-2E2Z]
INDICATI
Phase 1 Non-small cell lung cancer [ICD-11: 2C25]
INDICATI
Phase 1 Uterine ligament/parametrium/uterine adnexa neoplasm [ICD-11: 2C72]
INDICATI
Patented Human immunodeficiency virus disease [ICD-11: 1C60-1C62]
INDICATI
Patented Inflammatory liver disease [ICD-11: DB97]
INDICATI
Patented Postoperative inflammation [ICD-11: 1A00-CA43]